Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Conditionally MYC: insights from novel transgenic models.

Constadina Arvanitis1, Dean W Felsher

  • 1Departments of Medicine and Pathology, Division of Oncology, School of Medicine, Stanford University, CCSR 1105B, 269 Campus Drive, Stanford, CA 94305-5151, USA.

Cancer Letters
|July 26, 2005
PubMed
Summary

MYC oncogene inactivation can reverse cancer development. Recent studies show targeting MYC offers a promising and effective cancer treatment strategy across various cancer types.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Making the invisible visible: A global examination of careers and recognition for Imaging Scientists in core facilities.

Journal of microscopy·2026
Same author

EcDNA-borne structural variants drive oncogenic fusion transcript amplification.

Cell·2026
Same author

Targeting the MYC oncogene with a selective bi-steric mTORC1 inhibitor elicits tumor regression in MYC-driven cancers.

Cell chemical biology·2025
Same author

Apical size reduction by macropinocytosis alleviates tissue crowding.

Nature communications·2025
Same author

Trail-blazing and keeping pace: building, retaining and expanding image analysis expertise.

Frontiers in bioinformatics·2025
Same author

Artificial intelligence-powered microscopy: Transforming the landscape of parasitology.

Journal of microscopy·2025

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MYC is a well-known oncogene implicated in numerous cancers.
  • Its role in cancer pathogenesis has been recognized for decades.
  • The therapeutic potential of targeting MYC remained uncertain until recently.

Purpose of the Study:

  • To review experimental evidence on MYC inactivation as a cancer therapy.
  • To assess the efficacy and specificity of targeting MYC.

Main Methods:

  • Review of recent experimental model systems.
  • Analysis of data from conditional transgenic models demonstrating MYC inactivation.

Main Results:

  • Brief inactivation of MYC can lead to the reversal of established tumorigenesis.

Related Experiment Videos

  • Experimental models show MYC inactivation is feasible and effective.

    • Conclusions:

    • Targeting MYC represents a specific and effective therapeutic strategy for many cancers.
    • Further research into MYC-targeted therapies is warranted.